This is to our outcome of the Board Meeting held on September 01, 2025, wherein the Board of Directors of Vivanta Industries Limited ("the Company") approved the convening the Twelfth ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanta Industries Limited has issued the notice for its 12th Annual General Meeting scheduled for Tuesday, September 30, 2025 at 4:00 PM, to be held via video conferencing in compliance with MCA and SEBI circulars. Ordinary business includes adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, and re-appointment of Mr. Parikh H.A. (DIN: 00027820) as director, who retires by rotation. Special business seeks shareholder approval for material related party transactions with seven entities including Vipronova Lifescience, Adline Chem Lab, Vivanza Biosciences, and CKIM Pharma LLP for FY 2025-26. The meeting also seeks approval to appoint M/s. Jitendra Parmar & Associates as Secretarial Auditor for five consecutive years (FY 2025-26 to FY 2029-30) and a special resolution to alter the Main Object Clause of the Memorandum of Association to diversify into agro products, solar and renewable energy, drones, EV charging, IT and data centre businesses.
Shareholders should note that the e-voting window runs from September 27 to September 29, 2025, with September 23 as the cut-off date. The expansion of business objects and large related party transactions signal a major diversification push but also warrant scrutiny by minority shareholders, as related parties are barred from voting on the RPT resolution.